DoW Peer Reviewed Medical, Platform Clinical Translation Award
🏛 Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for research institutions, academic medical centers, and organizations developing clinical technologies for military service members, veterans, and their families.
Applicants must propose translational development and/or early-phase clinical trials addressing one of two congressionally directed FY26 PRMRP topic areas. Projects must have broadly applicable clinical technologies and address health care needs of military populations.
Multiple Principal Investigators (up to 3) can collaborate on a single project, with one designated as Initiating PI. All PIs must be appropriately credentialed for the proposed research. An external advisory board including a patient advocate is required.
Eligible organizations typically include 501(c)(3) nonprofits, academic institutions, government agencies, and commercial entities. The grant supports projects with a maximum 4-year period of performance and total cost cap of $15M per award.
Not the right fit? Find grants for your organization in 5 questions →
Program description
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families.
Distinctive Features:
Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas.
Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Translation Award applications with total cost caps of $15M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with a maximum of $8M in FY26, with the remaining budget to be funded out of future fiscal years depending upon meeting performance-based milestones and availability of future funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Who can apply
Eligible applicants
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- Application form (agency-specific)
- Project narrative/proposal
- Budget and budget narrative
- Biosketches for all PIs
- Advisory board documentation
- Letters of support from collaborating institutions
- Military relevance and clinical translation justification
Program contact
- 👤 Christopher L Baker Grants Officer
- 📧 help@eBRAP.org
- 📞 3016192332
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$74,531,880
-
$67,205,571
-
$55,443,120
-
$34,191,124
-
$24,907,742
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- CA 12 awards $107.3M
- FL 8 awards $99.8M
- TX 8 awards $76.5M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
What topics must my project address?
Your project must address one of two congressionally directed FY26 PRMRP topic areas. Check the full solicitation for current topic descriptions and strategic goals.
Can I have multiple Principal Investigators?
Yes, up to three PIs are allowed. One Initiating PI leads administration, and up to two Partnering PIs can collaborate. Each PI receives a separate award if funded.
Is an advisory board required?
Yes, a PI-convened external advisory board is required with at least one patient advocate. The advocate must have lived experience with the condition being addressed.
What is the funding timeline?
Awards receive maximum $8M in FY26, with remaining funds distributed in future years based on milestone achievement. Total award cap is $15M over 4 years. Funds expire September 30, 2032.
Who can apply as the applicant organization?
Research institutions, academic medical centers, nonprofits, government agencies, and commercial entities are typically eligible. Check the full solicitation for specific organizational requirements.
💡 Tips for applicants
- Start by identifying which of the two congressively directed FY26 topics your research best aligns with. Clear topical fit is essential for competitive review.
- Assemble your advisory board early, including a patient advocate with genuine lived experience. Reviewers carefully evaluate the quality of this partnership.
- Focus your project narrative on translational development or early clinical trials. This is not basic research—demonstrate clear clinical applicability and military relevance.
- Document how your platform technology addresses urgent needs for service members, veterans, or military families. Make the military health connection explicit throughout.
- Plan realistic milestones tied to funding tranches. Since funding is performance-based and spread across fiscal years, reviewers will scrutinize your ability to achieve interim goals.
⚠️ Common mistakes
Selecting a topic area misalignment or proposing basic research instead of translational/early clinical work. Failing to include or meaningfully engage a credible patient advocate on the advisory board from the start. Underestimating administrative complexity of multi-PI awards and unclear role definition among collaborating investigators.
Similar grants
- OPEN DoW Peer Reviewed Medical, Technology/Therapeutic Development Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Peer Reviewed Medical, Discovery Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Peer Reviewed Medical, Research Advancement Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Peer Reviewed Medical, Impact Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Peer Reviewed Medical, Lifestyle and Applied Health Research Award — Defense Health Agency Contracting Activity - DHACA